{
    "Trade/Device Name(s)": [
        "Dimension Vista Creatine Kinase (CKI) Flex Reagent Cartridge (K2038)",
        "Dimension Vista Creatine Kinase MB (MBI) Flex Reagent Cartridge (K2032)",
        "Dimension Vista (CKI) Flex Reagent Cartridge",
        "Dimension Vista (MBI) Flex Reagent Cartridge"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K083465",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081731"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGS",
        "JHS"
    ],
    "Summary Letter Date": "January 27, 2009",
    "Summary Letter Received Date": "January 28, 2009",
    "Submission Date": "November 18, 2008",
    "Regulation Number(s)": [
        "21CFR862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatine kinase",
        "Creatine kinase MB isoenzyme"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista clinical chemistry system"
    ],
    "Method(s)/Technology(ies)": [
        "Bichromatic rate detection",
        "Coupled enzyme reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista CKI and MBI Flex Reagent Cartridges for creatine kinase and creatine kinase MB measurement in serum and plasma.",
    "Indications for Use Summary": "Quantitative measurement of creatine kinase and creatine kinase MB isoenzyme activity in human serum and plasma to aid in the diagnosis and treatment of myocardial infarction and muscle diseases including progressive Duchenne-type muscular dystrophy.",
    "fda_folder": "Clinical Chemistry"
}